Alfred Mann Foundation chairman looks outward to extend founder ’ s legacy
When medtech pioneer Alfred Mann died in February 2016, he left behind a rich legacy of pure innovation and patient impact spanning the breadth of healthcare, from cardiology to hearing impairment, blindness and diabetes that will improve the lives of patients for decades to come. Extending and advancing that legacy is now the mission of Dr. Robert Greenberg, who took over as the foundation’s chairman in July. Speaking ahead of his appearance next week at MassDevice.com’s DeviceTalks West event in Costa Mesa, Greenberg told us that he’s looking to expand the foundation’s reach into the early-st...
Source: Mass Device - December 3, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Featured Funding Roundup Alfred Mann Foundation DeviceTalks West Source Type: news

Axonics Hopes to Surpass Medtronic in Sacral Neuromodulation Market
Axonics’ CEO Raymond Cohen wants to have the top spot in the sacral neuromodulation market when it comes to treating patients with urinary and fecal dysfunction. But to reach this position, Axonics is going to have some pretty stiff competition from one of the largest players in the game – Medtronic. And while going head-to-head with the medtech giant might be a lofty goal for some smaller companies, keep in mind the Irvine, CA-based company just raised $120 million in an initial public offering, one of the largest raises in the industry in the past few years. “Axonics ...
Source: MDDI - November 15, 2018 Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news

Baby hears for first time with cochlear implants
One month after 7-month-old Aida Little was born, her parents realized she couldn't hear. Experts at Mayo Clinic diagnosed Aida with a condition called Waardenburg syndrome, a rare genetic disorder that causes deafness and pigment changes of the hair, eyes and skin.? In October, a surgical team at Mayo placed cochlear implants into Aida's head [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - November 13, 2018 Category: Databases & Libraries Source Type: news

GI Dynamics eyes 2019 EU market return for EndoBarrier
GI Dynamics (ASX:GID) said yesterday that it tapped a new notified body in Europe, nearly a year after losing CE Mark approval there, as it eyes a market return for its EndoBarrier device by the end of next year. In the European Union, notified bodies are used as part of the regulatory system to assess product conformity. The erstwhile notified body for Boston-based GI Dynamics, SGS United Kingdom, last November took the company by surprise when it withdrew CE Mark certification for the EndoBarrier obesity and diabetes treatment. Yesterday GID said it named Intertek to replace SGS and review the technical fi...
Source: Mass Device - October 5, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Diabetes Featured Regulatory/Compliance Weight loss GI Dynamics Source Type: news

Can Medtech Manufacturing Benefit from Deep Learning?
Given medtech’s needs for high levels of quality and precision, machine learning could be put to good use in medical device manufacturing. One particular type of machine learning called “deep learning” could offer particular benefit as it could enable machine vision systems to learn how to recognize and respond to defects much like a human could, according to Bhaskar Ramakrishnan, technical sales engineer, DWFritz Automation. Ramakrishnan will be speaking about potential manufacturing roles for deep learning in the MD&M Minneapolis October 31 presentation, â&#...
Source: MDDI - October 4, 2018 Category: Medical Devices Authors: Daphne Allen Tags: MD & M Minneapolis Assembly and Automation Source Type: news

Second Sight Medical wins $2m NIH grant for Orion sight implant
Second Sight Medical (NSDQ:EYES) said today that it won a grant of nearly $2 million from the National Institutes of Health to back the early feasibility trial of its Orion device for the visually impaired. The Sylmar, Calif.-based company said the $1.6 million grant is part of a five-year, $6.3 million package that’s slated to fund the trial, which began in January. The NIH grant will cover the enrollment and treatment of five patients with Orion, a visual cortical implant that links to an eyeglass-worn camera, Second Sight said. The device is designed to bypass the optic nerve by sending the camera’s images t...
Source: Mass Device - September 18, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Funding Roundup Optical/Ophthalmic Source Type: news

Glaucoma Surgery Space Heats Up with New Approval
Glaukos has received FDA approval to market the iStent inject Trabecular Micro-Bypass System. The nod gives the San Clementa, CA-based company an opportunity to pull ahead of competition in the minimally invasive glaucoma surgery (MIGS) market. Glaukos said the iStent inject is designed to optimize the natural physiological outflow of aqueous humor by creating two patent bypasses through the trabecular meshwork, the main source of resistance in glaucomatous eyes, resulting in multi-directional flow through Schlemm’s canal. It includes two heparin-coated titanium stents preloaded into an auto-injection syst...
Source: MDDI - June 25, 2018 Category: Medical Devices Authors: Omar Ford Tags: Implants Source Type: news

FDA Approves First Artificial Iris
A German company has become the first to score FDA approval for a stand-alone prosthetic iris in the United States. The agency said Wednesday afternoon that it approved the CustomFlex Artificial Iris, made by Erlangen, Germany-based HumanOptics. The device, which is surgically implanted, is approved to treat adults and children whose iris is completely missing or damaged due to a congenital condition called aniridia or other damage to the eye. “Patients with iris defects may experience severe vision problems, as well as dissatisfaction with the appearance of their eye,” said Malvina Eydelman, MD, dire...
Source: MDDI - May 30, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: Implants Source Type: news

Glaucoma Device Makers See a Bright Future Ahead
Were The Graduate's Ben Braddock to receive a one-word bit of career advice today, it might very well be "MIGS" instead of plastics. MIGS stands for minimally invasive glaucoma surgery, and both financial analysts and developers of the tiny devices designed to treat the disease expect the market to pop for the foreseeable future. "On a scale of one through 10, I would say the market is probably somewhere between one and two in terms of maturity," said Dave Van Meter, CEO of Irvine, CA-based Ivantis. "The market in the U.S. today is probably somewhere around a couple hundred million dollars, ac...
Source: MDDI - May 11, 2018 Category: Medical Devices Authors: Greg Goth Tags: Implants Source Type: news

Curvy Instagram model, 32, left with 'the sight of a 90-year-old' after controversial procedure
Nadinne Bruna, 32, who lives in Miami, has lost most of her vision after undergoing treatment in Colombia, to insert silicone implants in her hazel eyes to turn them light grey. (Source: the Mail online | Health)
Source: the Mail online | Health - April 12, 2018 Category: Consumer Health News Source Type: news

Nadinne Bruna has 'sight of 90-year-old' after eye colour procedure
Nadinne Bruna, 32, who lives in Miami, has lost most of her vision after undergoing treatment in Colombia, to insert silicone implants in her hazel eyes to turn them light grey. (Source: the Mail online | Health)
Source: the Mail online | Health - April 12, 2018 Category: Consumer Health News Source Type: news

Edwards Eyes Delay for its Sapien 3 Ultra TAVR
Edwards Lifesciences said it is delaying the launch of the Sapien 3 Ultra transcatheter aortic valve replacement (TAVR) System in Europe until later this year. The Irvine, CA-based company said it would refocus on commercialization efforts after it submits data from the 30-patient, single-arm study of the device treating patients at intermediate risk from surgical valve replacement. The study data would help supplement the company’s bid to gain CE mark for the technology. Edwards said the updated timing for the European launch of the Sapien 3 Ultra doesn’t change the company’s sales guidance for 2018...
Source: MDDI - March 22, 2018 Category: Medical Devices Authors: Omar Ford Tags: Implants Source Type: news

Glaukos touts IOP, medication use reductions in iStent trial
Glaukos (NYSE:GKOS) today released results from a study of its iStent trabecular micro-bypass stent exploring its use during cataract surgery in patients with severe open-angle glaucoma, touting significant reductions in intraocular pressure and medication use. The San Clemente, Calif.-based company’s iStent micro-bypass stents are made from non-ferromagnetic titanium and coated in heparin, is designed to be implanted into multiple trabecular meshwork through a single corneal entry point to reduce IOP. Results were published in the January issue of the Journal of Glaucoma. “Although the iStent&nb...
Source: Mass Device - February 8, 2018 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Optical/Ophthalmic Glaukos Source Type: news

How to Make Medical Devices Like a Magician
John Crombie has a few tricks up his sleeve and this magician isn't afraid to reveal his secrets. During a product development workshop at MD&M West this week, Crombie explained how to apply the art of magical illusion to your next product development project. First, Crombie performed what is known as the Penna coin trick in which he showed his spectators a glass that had a piece of rubber covering the top and secured with a rubber band a quarter on top. He then asked an audience volunteer to push down on the quarter with his finger, giving the illusion that the coin had passed through the piece of rubber into the...
Source: MDDI - February 7, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: MD & M West (Anaheim) R Source Type: news

Second Sight touts 1st-in-human Orion cortical implant
Second Sight Medical (NSDQ:EYES) today announced the first trial implantation of its Orion cortical visual prosthesis system and updated on implantations of its Argus device and enrollment in an upcoming study. The first implantation procedure was performed late last month by Dr. Nader Pouratian at the Ronald Reagan UCLA Medical Center, the Sylmar, Calif.-based company said, as part of an FDA-cleared feasibility trial it won approval to launch last November. The Orion cortical visual prosthesis system is designed to convert images captured by a miniature video camera, mounted on a patient’s glasses, into a ...
Source: Mass Device - February 5, 2018 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Optical/Ophthalmic Second Sight Source Type: news

These medtech companies raised the most VC last year
[Image from unsplash.com]Perhaps there’s a ray of hope that venture capital funding is recovering a bit for the medical device industry. VC firms invested more than $2.8 billion in 2017, an increase of more than $647 million from 2016, according to the MoneyTree Report from PricewaterhouseCoopers (PwC) and CB Insights. There were a total 229 deals involving medical device companies last year. The companies raking in the VC cash are doing everything from creating robotic microsurgery for the eyes to building better dialysis machines to bringing neuromodulation to bear on epilepsy. Read on to discover which medtech com...
Source: Mass Device - January 19, 2018 Category: Medical Devices Authors: Danielle Kirsh Tags: Cardiovascular Funding Roundup Hospital Care Implants mHealth (Mobile Health) Advanced Cardiac Therapeutics Inc. Auris Surgical Robotics Cereve EarLens Ebb Therapeutics EBR Systems Inc. Fractyl Laboratories immusant MedTech Mox Source Type: news

Thai woman left with silicone implant between her eyes  
The unnamed woman, from Hat Yai in the south of the country, opted for a cheap rhinoplasty operation at a clinic that later refused to help her, local reports state. (Source: the Mail online | Health)
Source: the Mail online | Health - December 27, 2017 Category: Consumer Health News Source Type: news

Second Sight launches Argus retinal prosthesis in Iran
Second Sight Medical (NSDQ:EYES) said today it launched its Argus II retinal prosthesis system in Iran, facilitated through its exclusive distribution partner Arshia Gostar Darman. The Sylmar, Calif.-based company said that the system has been implanted in two patients in the country, with the procedures performed by Dr. Mohsen Farvadin at the Shiraz Pars Hospital and Khalili Hospital, Shiraz Medical Science University in 44-year old and 33-year old patients with retinitis pigmentosa. The Argus II induces visual perception in blind patients with retinitis pigmentosa by stimulating of the retina’s remaining ...
Source: Mass Device - December 5, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Optical/Ophthalmic Second Sight Source Type: news

Could an Implant Be Developed to Help Restore Sight?
Scientists from a biomedical research consortium could help a U.S. government funded program aiming to restore sensory perception. The U.S. Defense Advanced Research Projects Agency (DARPA) established the Neural Engineering System Design program (NESD) to encourage development of “an implantable neural interface able to provide unprecedented signal resolution and data-transfer bandwidth between the human brain and the digital world,” according to DARPA’s Web site. DARPA has awarded six NESD contracts, one of which was given to CorticalSight, a program by the Seeing and Hearing Foundation (Fondation Voir ...
Source: MDDI - November 30, 2017 Category: Medical Devices Authors: Daphne Allen Tags: Implants Source Type: news

Report: India eyes penalties for Johnson & Johnson over metal-on-metal hips
Johnson & Johnson (NYSE:JNJ) could reportedly be on the hook again for the metal-on-metal hip implants it pulled from the market in 2010, this time in India and for much less than it’s cost the company elsewhere. The world’s second-largest medical device maker has fielded numerous lawsuits about its ASR metal-on-metal hip replacement since it pulled the ASR XL Acetabular and ASR Hip Resurfacing systems from the market in August 2010, “due to the number of patients who required a second hip replacement procedure, called a revision surgery.” Three years later Johnson ...
Source: Mass Device - November 20, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Legal News Metal-on-Metal johnsonandjohnson Source Type: news

Baby born with no eyes needs bionic implants
Archie Innes was born with a rare genetic disorder that has left him 'black blind'. Mother Fiona Gould, living in Sydney and originally from Kent, has raised £6,000 in just two days for the innovative treatment. (Source: the Mail online | Health)
Source: the Mail online | Health - November 16, 2017 Category: Consumer Health News Source Type: news

FDA puts Second Sight Medical ’ s next-gen Orion ‘ bionic eye ’ on the fast track
Second Sight Medical (NSDQ:EYES) said today that the FDA put its Orion “bionic eye” on the fast track to approval. The Orion device is a cortical visual prosthesis that uses a camera and a brain implant to bypass the optic nerve in visually impaired patients. The federal safety watchdog put the device on its expedited access pathway, giving Sylmar, Calif.-based Second Sight priority review, greater interactive review for both its investigational device exemption and pre-market approval bids, plus more emphasis on post-market studies rather than pre-market clinical work. The FDA will also assign a cross-discipli...
Source: Mass Device - November 8, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Food & Drug Administration (FDA) Optical/Ophthalmic Regulatory/Compliance Second Sight Source Type: news

The eyes have it: how technology allows you to speak when all you can do is blink
Developments in eye-gaze technology – which converts minute movements of the eye into spoken words – are opening up undreamed of opportunities for people with motor neurone syndromeSteve Thomas and I are talking about brain implants. Bonnie Tyler ’s Holding Out For a Hero is playing in the background and for a moment I almost forget that a disease has robbed Steve of his speech. The conversation breaks briefly; now I see his wheelchair, his ventilator, his hospital bed.Steve, a software engineer, was diagnosed with ALS (amyotrophic lateral sclerosis, a type ofmotor neurone disease) aged 50. He knew i...
Source: Guardian Unlimited Science - October 16, 2017 Category: Science Authors: Jules Montague Tags: Motor neurone disease Medical research Technology Society Science Health & wellbeing Life and style Source Type: news

7 medtech stories we missed this week: Oct. 6, 2017
[Image from unsplash.com]From Intellijoint’s CE Mark to Patrona Medical and Kopis’ new partnership, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Intellijoint CE Mark for flagship hip navigation Intellijoint surgical announced in an Oct. 4 press release that it has received CE Mark for its Intellijoint HIP System in Europe. The device is a 3D mini-optical navigation system that gives surgeons precise measurement for cup position, leg length and offset of total hip arthroplasty. It doesn’t require any pre-operative or intra-operative imaging and can be used ...
Source: Mass Device - October 6, 2017 Category: Medical Devices Authors: Danielle Kirsh Tags: 510(k) Biotech Blood Management Catheters Clinical Trials Food & Drug Administration (FDA) Hospital Care Optical/Ophthalmic Patient Monitoring Regulatory/Compliance Research & Development Adhezion Biomedical Bio-Tissue Inc. DiscG Source Type: news

Nerve implant 'restores consciousness' to man in vegetative state
Stimulation of the vagus nerve allows patient who has been in a vegetative state for 15 years to track objects with his eyes and respond to simple requestsA 35-year-old man who had been in a vegetative state for 15 years has shown signs of consciousness after receiving a pioneering therapy involving nerve stimulation.The treatment challenges a widely-accepted view that there is no prospect of a patient recovering consciousness if they have been in a vegetative state for longer than 12 months.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - September 25, 2017 Category: Science Authors: Hannah Devlin Science correspondent Tags: Neuroscience Medical research Source Type: news

Nerve implant 'restores consciousness' to man in persistant vegetative state
Stimulation of the vagus nerve allows patient who had been in a persistant vegetative state for 15 years to track objects with his eyes and respond to simple requestsA 35-year-old man who had been in a persistant vegetative state (PVS) for 15 years has shown signs of consciousness after receiving a pioneering therapy involving nerve stimulation.The treatment challenges a widely-accepted view that there is no prospect of a patient recovering consciousness if they have been in PVS for longer than 12 months.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - September 25, 2017 Category: Science Authors: Hannah Devlin Science correspondent Tags: Neuroscience Medical research Source Type: news

Nerve implant 'restores consciousness' to man in persistent vegetative state
Stimulation of the vagus nerve allows patient who had been in a persistent vegetative state for 15 years to track objects with his eyes and respond to simple requestsA 35-year-old man who had been in a persistent vegetative state (PVS) for 15 years has shown signs of consciousness after receiving a pioneering therapy involving nerve stimulation.The treatment challenges a widely-accepted view that there is no prospect of a patient recovering consciousness if they have been in PVS for longer than 12 months.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - September 25, 2017 Category: Science Authors: Hannah Devlin Science correspondent Tags: Neuroscience Medical research Source Type: news

FDA clears Second Sight IDE trial of next-gen Orion cortical visual prosthesis
Second Sight Medical (NSDQ:EYES) said today it won FDA investigational device exemption to initiate a feasibility clinical study of its Orion cortical visual prosthesis system. The conditional approval gives the Sylmar, Calif.-based company clearance to enroll up to 5 patients at 2 US sites, but requires that the company conduct additional device testing and “address outstanding questions” within 45 days, it said. “This is an exciting milestone for the company given the potential of Orion to provide useful vision to millions of blind individuals worldwide who have no other option today. We are deligh...
Source: Mass Device - August 28, 2017 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Food & Drug Administration (FDA) Optical/Ophthalmic Prosthetics second-sight-medical Source Type: news

Abbott launches trial of transcatheter tricuspid repair device, eyes CE Mark
Abbott (NYSE:ABT) said today it enrolled the 1st patient in a clinical trial of a minimally invasive, clip-based transcatheter valve repair system for treating patients with severe tricuspid regurgitation, looking to eventually support CE Mark approval in the European Union. The 1st patient in the trial was enrolled at the Abbott Northwestern Hospital by Dr. Paul Sorajja of the Minneapolis Heart Institute, the Abbot Park, Ill.-based company said. The transcatheter tricuspid valve repair system is built off of technology which has been tested with the company’s MitraClip system, designed to treat mitral valv...
Source: Mass Device - August 9, 2017 Category: Medical Devices Authors: Fink Densford Tags: Cardiac Implants Cardiovascular Clinical Trials Replacement Heart Valves Abbott Source Type: news

Simulations signal early success for fractal-based retinal implants
(University of Oregon) Computer simulations of electrical charges sent to retinal implants based on fractal geometry have University of Oregon researchers moving forward with their eyes focused on biological testing. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 27, 2017 Category: International Medicine & Public Health Source Type: news

Second Sight Medical enters Russian market
Second Sight Medical (NSDQ:EYES) said today it entered the Russian market, with the 1st patient treated with its Argus II Retinal Prosthesis System in Moscow. The Argus II induces visual perception in blind patients with retinitis pigmentosa by stimulating of the retina’s remaining cells with electrical pulses, which allows for the perception of light patterns to the brain, the Sylmar, Calif.-based company said. The 1st implant was performed at the Federal State Institution & Clinical Research Center of the Federal Medico-Biological Agency at the end of June 2017 by a team of surgeons, with Dr. Paulo Stanga ...
Source: Mass Device - July 26, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Optical/Ophthalmic second-sight-medical Source Type: news

Researchers use magnetic implants to treat 'dancing eyes'
Scientists are using magnetic implants inserted behind the eye to treat nystagmus, a condition causing involuntary eye movements, or dancing eyes. (Source: Health News - UPI.com)
Source: Health News - UPI.com - June 26, 2017 Category: Consumer Health News Source Type: news

Magnets used to control flickering eyes
A case study has shown how magnetic implants in the eye can successfully control the movement of the eye. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - June 26, 2017 Category: Consumer Health News Source Type: news

7 medtech stories we missed this week: June 23, 2017
[Image from unsplash.com]From Guardant suing Foundation Medicine to Interson receiving 510(k) clearance for ultrasound probes, here are 7 medtech stories we missed this week but thought were still worth mentioning. 1. Guardant levels false advertising suit against Foundation Medicine Guardant Health announced in a June 22 press release that it has filed a lawsuit against Foundation Medicine for false advertising and unfair competition. Guardant Health is claiming that Foundation Medicine’s advertising causes harm to Guardant Health and its patients because it misleads oncologists about the sensitivity and accuracy of...
Source: Mass Device - June 23, 2017 Category: Medical Devices Authors: Danielle Kirsh Tags: 510(k) Business/Financial News Clinical Trials Food & Drug Administration (FDA) Implants Neurological Regulatory/Compliance Ultrasound EndoStim Foundation Medicine Inc. Guardant Health Interson Lee's Pharmaceutical Meditech Med Source Type: news

Model With Rare Genetic Disorder Is A Brilliant Example Of Inclusion
This world is a diverse one, so it’s refreshing when the fashion industry reflects that reality. And Seattle-based model Melanie Gaydos is hoping to add to that effort. Gaydos, 28, was born with ectodermal dysplasia, a genetic disorder that can interfere with the proper growth of the hair, nails, teeth, skin and glands. Her involvement in the fashion community is helping people like her to see a place for them in the highly stylized world of modeling. A post shared by Melanie Gaydos (@melaniegaydos) on May 17, 2017 at 5:12pm PDT Fewer than 200,000 people in the United States experience the rare condition,&...
Source: Healthy Living - The Huffington Post - June 8, 2017 Category: Consumer Health News Source Type: news

2 Massachusetts Women, Thousands Nationwide Say Breast Implants Made Them Sick
BOSTON (CBS) – Just a few months ago, the idea of lacing up her sneakers and going out for a run was impossible for Meghan Sullivan. “It got to a point where I couldn’t get out of bed anymore. I was in that much pain,” she said. The single mother from Hingham says she broke out into a terrible rash, her face was swollen, she had joint pain and barely had the energy to take care of her 7-year-old son. “It was hard. It was emotional. It was scary for me. I couldn’t live normally,” she said with tears welling up in her eyes. Kaylee Silcox of Quincy was just 24 when she got sick. &ldqu...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - May 10, 2017 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health Local News Syndicated Local breast implant illness Dr. Mallika Marshall Source Type: news

Second Sight shares drop on Q1 miss
Shares in Second Sight Medical (NSDQ:EYES) have dropped today after the medical device maker missed expectations on Wall Street with its 1st quarter results. The Sylmar, Calif-based company posted losses of $7.5 million, or 16¢ per share, on sales of $1 million for the 3 months ended March 31, seeing losses grow 29.8% while sales shrunk 4.2% compared with the same period during the prior year. Analysts on Wall Street were expecting to see losses per share of 14¢, which Second Sight medical came in just above. “With a focus on execution and our centers of excellence strategy, we had strong implant volume dur...
Source: Mass Device - May 4, 2017 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News MassDevice Earnings Roundup second-sight-medical Source Type: news

We Know How To Curb Epidemics. Can Alzheimer's Be Next?
I travel a lot, which means I spend much of my time in airports waiting to catch a flight. I use most of that time to work or catch up on email, but sometimes, when it’s really early in the morning or really late at night, I just sit at the gate and watch the people go by. And not too long ago I saw something that broke my heart. It was a couple my age, maybe a few years older. They were making their way to the gate. They were ordinary-looking folks, but as I looked at them closely I noticed that something wasn’t quite right. The man seemed confused, disoriented, distressed. The woman seemed stricken, sad. She ...
Source: Healthy Living - The Huffington Post - April 27, 2017 Category: Consumer Health News Source Type: news

PVR and Steroid Implants -- A Good Fit? PVR and Steroid Implants -- A Good Fit?
Have dexamethasone implants changed the treatment landscape of proliferative vitreoretinopathy? Dr Sophie Bakri'eyes'the latest research.Medscape Ophthalmology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 13, 2017 Category: Consumer Health News Tags: Ophthalmology Viewpoint Source Type: news

Terumo taps DeRyke as CV CEO | Personnel Moves – April 7, 2017
Terumo Corp. (TYO:4543) said yesterday it tapped Rob DeRyke as its new CV group prez & CEO, effective April 1, 2017, succeeding a retiring Mark Sutter. Prior to his appointment, DeRyke operated as Terumo CV group electromechanical systems division prez, the company said. “Under his leadership, Rob brought stability and improved profitability to the business,” Terumo Corp prez & CEO Shinjiro Sato said in a press release. DeRyke joined Terumo in 2012 as corporate quality VP, and has 25 years of experience in med device and pharmaceuticals, the company said. He has previously held positions at Ba...
Source: Mass Device - April 7, 2017 Category: Medical Equipment Authors: MassDevice staff Tags: Business/Financial News Active Implants AdvaMed Alphatec Holdings Inc. Anika Therapeutics Inc. Apollo Endosurgery Aurora Spine Baxter Biocorp Biogen Idec Biolase Technology Inc Bioventus LLC Bonesupport Clal Biotech Delcath Sys Source Type: news

VisionCare launches new clinical trial for telescope implant
VisionCare, Inc. said this week that the FDA approved its investigational device exemption for a new clinical trial in the U.S. evaluating its telescope implant in patients with end-stage macular degeneration. The Saratoga, Calif.-based company’s implantable miniature telescope, which was developed by Israeli inventor Dr. Isaac Lipshitz, is contraindicated for patients with previous intraocular or corneal surgery of any kind. This new clinical trial will study the effectiveness of the telescope implant in patients who were previously implanted with an intraocular lens. “The average patient, at least in Nor...
Source: Mass Device - January 13, 2017 Category: Medical Equipment Authors: Sarah Faulkner Tags: Clinical Trials Implants Optical/Ophthalmic Surgical VisionCare Ophthalmic Technologies Source Type: news

Reflections on the Future of Medicine
Recently, I traveled through China. I climbed mountains, hiked through forests, crossed deep valleys. I visited cities of every size. I floated across lakes and traveled beautiful shorelines churning with life. As a man of a certain age, I began to compare the permanence of the timeless landscape with the evanescence of my own existence. Yet, as a scientist, I knew these reflections were flawed. Scientists are trained to think in terms of aeons, millenia, and lifetimes. Consider the paradox. Is it the solid mountain or fragile the forest that is permanent? Is it the massive shoreline cliffs or the teeming shore life that...
Source: Science - The Huffington Post - January 9, 2017 Category: Science Source Type: news

Presbia announces 2-year Microlens data from PMA trial
Presbia (NSDQ:LENS) touted interim data today from its U.S. pivotal clinical trial, which it hopes will eventually support pre-market approval from the FDA for its Flexivue Microlens. The company is 2 years into the 3-year long trial and said that it anticipates submitting final data to the FDA in September 2017. The company’s lens is intended to correct presbyopia, farsightedness that is often age-related. Presbia’s custom lenses are implanted in the patient’s non-dominant eye in the hopes of helping the patient see near objects more clearly. To place the microlens in a patient’...
Source: Mass Device - December 23, 2016 Category: Medical Equipment Authors: Sarah Faulkner Tags: Clinical Trials Food & Drug Administration (FDA) Implants Optical/Ophthalmic Regulatory/Clearance Presbia Source Type: news

Blind patients to get bionic eyes in 2017: NHS to pay for 10 people to be fitted with eyes
THE NHS will pay for 10 people with an inherited form of blindness to be fitted with "bionic eye" implants. (Source: Daily Express - Health)
Source: Daily Express - Health - December 22, 2016 Category: Consumer Health News Source Type: news

Aesthetics at the International Dental Show (IDS) 2017: Ceramic innovations inspire
Precoloured veneering ceramics - infiltration method, staining techniques - economic production options for aesthetic restorations - a central theme of IDSPeople, who have beautiful eyes and lovely teeth, are beautiful. Because that is what the eye of the onlooker perceives first. The proportions have to be right and form a harmonious whole. As far as teeth are concerned, the dental industry has created a host of innovative methods and products over the past decades, which narrow the gap more and more between a high ideal and the achievable reality. These include modern diagnosis and therapy options (i.e. face scanners, ba...
Source: Dental Technology Blog - September 14, 2016 Category: Dentistry Source Type: news

Why Taller People May Be Better At Judging How Far Away Things Are
Tall people are better than short people at gauging how far away they are from objects in the middle distance, a new study reports. The researchers say the results are evidence for the idea that people’s spatial perception abilities are influenced by their height, and develop over time. The human brain depends on a certain model to provide “the best guess of where objects could be located,” said study co-author Teng Leng Ooi, a professor of optometry at The Ohio State University. That model, or “intrinsic bias,” is typically revealed when people have very little information about where an obje...
Source: Healthy Living - The Huffington Post - September 6, 2016 Category: Consumer Health News Source Type: news

MassDevice.com +5 | The top 5 medtech stories for August 18, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. HeartWare recalls some HVAD implantable heart pumps on electrical fault risk HeartWare International this week recalled some of its HVAD implantable heart pumps on the risk of electrical faults from driveline contamination. The ...
Source: Mass Device - August 18, 2016 Category: Medical Equipment Authors: MassDevice Tags: News Well Plus 5 Source Type: news

Should Women Have Breast Implants Removed?
It was a story with a bit of irony, as well as ominous health warnings. Crystal Hefner, the 30-year-old wife of Playboy magazine mogul Hugh Hefner, announced in a story in People magazine last month that she'd had her breast implants removed because they were making her sick. Hefner posted a photo of her post-surgery self on Instagram with the caption, "Using 2016 to reclaim my health and embrace and love myself for the real me." The former model, now a DJ, was diagnosed a few months back with Lyme disease. Her symptoms included intolerance to foods and beverages as well as back, neck, and shoulder pain. Hefn...
Source: Healthy Living - The Huffington Post - August 2, 2016 Category: Consumer Health News Source Type: news

MassDevice.com +5 | The top 5 medtech stories for July 14, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. Endotronix raises $32m Series C for wireless heart monitor Endotronix said today that it raised a $32 million Series C round for the wireless heart monitor it’s looking to commercialize. Participants in the round included...
Source: Mass Device - July 14, 2016 Category: Medical Equipment Authors: MassDevice Tags: News Well Plus 5 Source Type: news